Affymax

Affymax's email is info@affymax.com and Affymax's phone number is (650) 812-8700 .
Affymax is a biopharmaceutical company committed to developing novel drugs to improve the treatment of serious and often life-threatening conditions. The company's first product candidate, peginesatide (formerly known as Hematideâ„¢), has been investigated in Phase 3 trials for the potential treatment of anemia associated with chronic kidney disease (CKD). A New Drug Application (NDA) for peginesatide for the treatment of anemia associated with CKD in adult patients on dialysis is currently being reviewed by the U.S. Food and Drug Administration (FDA).
View Top Employees for Affymax
img Industry Biotechnology
img Location United States
img Employees 30
img HQ 19200 Stevens Creek Blvd. Suite 240
img Phone (650) 812-8700
img Email info@affymax.com
img Funding 172,999,999 USD
img Competitors Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences,
img Industry Biotechnology
img Location United States
img Employees 30
img LinkedIn linkedin.com/company/affymax
img HQ 19200 Stevens Creek Blvd. Suite 240
img Phone (650) 812-8700
img Email info@affymax.com
img Funding 172,999,999 USD

Top Competitors